Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic Lymphocytic Leukemia
Suang Min Lim , Jeong Won Jang , Byung Wook Kim , Hwang Choi , Kyu Yong Choi , Soo Jeong Park , Chi Wha Han
It is generally accepted that seroconversion of hepatitis B virus (HBV) surface antigen (HBsAg) to an antibody to HBsAg (anti-HBs) indicates clearance of HBV. Here we report a case of severe hepatitis that manifested during chemotherapy in a female patient with chronic lymphocytic leukemia (CLL) who had been initially seronegative for HBsAg and seropositive for anti-HBs. The patient received chlorambucil and prednisolone for the treatment of CLL. After 6 months the serum levels of aminotransferases were increased, and HBsAg and HBV DNA were present in serum. Lamivudine was administered immediately after confirming the HBV reactivation, which considerably improved jaundice and aminotransferase levels after 3 weeks. The patient was able to resume the chemotherapy whilst continuing lamivudine treatment. This case report highlights the need for physicians to be aware of the potential risk of HBV reactivation even in an HBsAg- negative person but with detectable anti-HBc and/or anti-HBs, underscoring the need for future studies that explore the role of antiviral prophylaxis in this setting. (Korean J Hepatol 2008;14:213-218)
Reactivation of hepatitis B (reverse seroconversion) after melphalan/dexamethasone therapy for primary amyloidosis: a case report Woo-Ram Moon, Do-Sik Moon, JoA Kim, Young-min Yoon, Byung-Seok Choi, Choon-Hae Chung, Sang-Gon Park Journal of Medical Case Reports.2015;[Epub] CrossRef
Localized and Systemic Approaches to Treating Hepatocellular Carcinoma Jennifer J. Knox, Sean P. Cleary, Laura A. Dawson Journal of Clinical Oncology.2015; 33(16): 1835. CrossRef
A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma Tae Won Lim, Hee Taek Oh, Seung Un Song, Hae Won Lee, Ji Yeon Kim, Seon Ja Park Kosin Medical Journal.2014; 29(2): 161. CrossRef
Hepatitis B virus management to prevent reactivation after chemotherapy: a review Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba Supportive Care in Cancer.2012; 20(11): 2999. CrossRef
Factors associated with hepatic dysfunction in hepatitis B-positive patients with postgastrectomy adenocarcinoma JIAN XU, HONG ZHU, YAQIN ZHAO, XIN WANG, YALI SHEN, WU WANG, FENG XU Oncology Letters.2012; 4(3): 471. CrossRef
Fulminant Hepatic Failure with Hepatitis B Virus Reactivation after Rituximab Treatment in a Patient with Resolved Hepatitis B Seong Min Chung, Joo Hyun Sohn, Tae Yeob Kim, Ki Deok Yoo, Yong Woo Ahn, Joong Ho Bae, Yong Cheol Jeon, Jung Hye Choi The Korean Journal of Gastroenterology.2010; 55(4): 266. CrossRef
